Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia.

Andrea BakerLachlan ClarkePeter DonovanJacobus P J UngererGunter HartelGeorge BruxnerLuca CocchiAnne GordonVikas MoudgilGail RobinsonDigant RoyRavinder SohalEmma WhittleJames G Scott

Published in: Trials (2021)

Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12621000327886 . Registered on 23 March 2021.

Keyphrases

clinical trial
phase ii
bipolar disorder
small molecule
open label
study protocol
high throughput
randomized controlled trial
combination therapy
replacement therapy
smoking cessation